Cheil Bio Co Ltd
052670
Company Profile
Business description
Cheil Bio Co Ltd is a Korea-based company involved in the manufacturing of veterinary drugs. Its offerings consist of antibiotics, antimicrobials, lactobacillus, enzyme preparations, parasiticides, antiseptics, organic trace minerals, vaccines, diagnostic kits including enzyme-linked immunosorbent assay (ELISA) test kits, virus test kits, and deoxyribonucleic acid (DNA) kits, as well as feed additives. The company's products are used for cattle, pigs, chickens, pets and other animals.
Contact
Number 1601, 767, Sinsu-ro, Suji-gu
Gyeonggi-do
Yongin-si16827
KORSector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 December 2025
Employees
48
Stocks News & Analysis
stocks
Chart of the Week: Aussie dividend yields are less attractive than alternatives
The latest insights from our equity research team.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,854.90 | 11.80 | 0.13% |
| CAC 40 | 8,086.05 | 20.11 | -0.25% |
| DAX 40 | 23,960.59 | 116.28 | -0.48% |
| Dow JONES (US) | 47,885.97 | 228.29 | -0.47% |
| FTSE 100 | 9,774.32 | 89.53 | 0.92% |
| HKSE | 25,436.60 | 32.18 | -0.13% |
| NASDAQ | 22,693.32 | 418.14 | -1.81% |
| Nikkei 225 | 49,006.89 | 505.39 | -1.02% |
| NZX 50 Index | 13,247.06 | 48.85 | -0.37% |
| S&P 500 | 6,721.43 | 78.83 | -1.16% |
| S&P/ASX 200 | 8,568.90 | 12.40 | 0.14% |
| SSE Composite Index | 3,875.97 | 5.69 | 0.15% |